Tech Company Financing Transactions
Euthymics Bioscience Funding Round
Private investors participated in a $7.5 million capital raise for Euthymics Bioscience. The round was announced on 4/2/2014.
Transaction Overview
Company Name
Announced On
4/2/2014
Transaction Type
Venture Equity
Amount
$7,500,273
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anthony McKinney
Chief Marketing Officer
Katherine Laessig
Browse more venture capital transactions:
Prev: 4/2/2014: Sookasa venture capital transaction
Next: 4/2/2014: Wealthfront venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs